FDA Inspection 904602 — Adare Pharmaceuticals, Inc.
The FDA completed an inspection of Adare Pharmaceuticals, Inc. on Nov 14, 2014 in Vandalia, OH. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 14, 2014
- Fiscal Year
- 2015
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Vandalia, OH (United States)